Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ADDENTAX GROUP CORP.ATXG · Entity 8354 | Director | September 08, 2025 | November 19, 2025 |
| MANGOCEUTICALS, INC.MGRX · Entity 8073 | Director | July 28, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ADDENTAX GROUP CORP.
Report date September 08, 2025 · Filed November 19, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-09-08 transaction · row 1
1 source rowRow 1 · 2025-09-08 · Sale · Disposed 23,095 · Balance 0 |
MANGOCEUTICALS, INC.
Report date July 28, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 101,667 |
Reported balance
After 2026-07-28 transaction · row 1
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 100,000 · Balance 101,667 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-045855 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,667 Read SEC document |
| November 19, 2025 Filed Nov 26, 2025 16:30 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | SaleCommon Stock | 125,000 | $1.22 | $152,875.00 |
DisclosureSEC source: 0001493152-25-025163 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,334 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.195 to $1.2465, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 09, 2025 Filed Sep 12, 2025 16:57 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-027217 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,667 F1 · kind: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| September 08, 2025 Filed Nov 19, 2025 11:43 UTC | ADDENTAX GROUP CORP. ATXG · Entity 8354 | SaleCommon Stock | 23,095 | $0.52 | $12,009.40 |
DisclosureSEC source: 0001493152-25-024186 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 16:05 UTC | ADDENTAX GROUP CORP. ATXG · Entity 8354 | GrantCommon Stock | 23,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-023474 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,095 F1 · shares: Represents shares issued to the Reporting Person pursuant to the Issuer's 2024 Equity Incentive Plan. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003875 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,334 F1 · kind: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
| June 26, 2024 Filed Jun 27, 2024 18:25 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | SaleCommon Stock | 108,426 | $0.32 | $34,696.32 |
DisclosureSEC source: 0001493152-24-025489 · ownership.xml · nonDerivative · entry 2 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F2 · price: This transaction was executed in multiple trades at prices ranging from $0.33 to $0.32, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 25, 2024 Filed Jun 27, 2024 18:25 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | SaleCommon Stock | 16,574 | $0.31 | $5,137.94 |
DisclosureSEC source: 0001493152-24-025489 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,426 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.32 to $0.31, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 17:15 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022805 · ownership.xml · nonDerivative · entry 1 Hamilton Alex P. · CIK 0001970448 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 F1 · kind: Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.